2020
DOI: 10.1016/j.vaccine.2020.11.031
|View full text |Cite
|
Sign up to set email alerts
|

Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008–2017: Essential information for rational vaccine design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 48 publications
2
22
0
Order By: Relevance
“…And Loop prediction is consistent with neutralizing linear epitopes from previous report (Xu et al, 2017). Thus, D3 strain is a candidate for developing a CVA6 vaccine (Hoa-Tran et al, 2020). The CVA6 D3 subtype epidemic strains exhibit stronger transmission ability, infectivity and virulence, which might be associated with a CVA6 epidemic (Song et al, 2017).…”
Section: Discussionsupporting
confidence: 82%
See 3 more Smart Citations
“…And Loop prediction is consistent with neutralizing linear epitopes from previous report (Xu et al, 2017). Thus, D3 strain is a candidate for developing a CVA6 vaccine (Hoa-Tran et al, 2020). The CVA6 D3 subtype epidemic strains exhibit stronger transmission ability, infectivity and virulence, which might be associated with a CVA6 epidemic (Song et al, 2017).…”
Section: Discussionsupporting
confidence: 82%
“…Since 2008, genotype D3 strain gradually becomes the main epidemic strain worldwide. In addition, although sporadic substitutions were found among a few CVA6 epidemic strains, the amino acid sequences were highly conservative by predicted putative functional loops located in the VP4, VP2, VP3, and VP1 of CVA6 ( Hoa-Tran et al., 2020 ). And Loop prediction is consistent with neutralizing linear epitopes from previous report ( Xu et al., 2017 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…During the last decade, coxsackievirus A6 (CV-A6) has been implicated in large outbreaks with atypical HFMD cases. [ 10 , 11 ] However, the risk of severe neurological complications due to CV-A6 would be relatively lower than EV-A71. Currently, multivalent vaccines containing different NPEV antigens are being developed in China and other countries, but further vaccine and vaccination strategies need to be established based on the sensitive disease and enterovirus surveillance and careful evaluation of disease burden in the enterovirus-associated diseases.…”
mentioning
confidence: 99%